Additional file 6 of Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma

Additional file 6: Table S1. Information of ccRCC tissue microarray. Table S2. Patient information for samples enrolled in the study (ccRCC tissue microarray). Table S3. Antibody panel used for acquiring images with IMC. Table S4. Details of IMC acquired images. Table S5. Cell type annotation rules. Table S6. Information of patients receiving targeted therapy and/or immunotherapy.

补充材料6：表S1 肾透明细胞癌（clear cell renal cell carcinoma, ccRCC）组织微阵列信息。
表S2 本研究纳入的ccRCC组织微阵列样本的患者信息。
表S3 用于成像质谱流式细胞术（Imaging Mass Cytometry, IMC）图像采集的抗体组合。
表S4 IMC采集图像的详细信息。
表S5 细胞类型注释规则。
表S6 接受靶向治疗和/或免疫治疗的患者信息。